Conference On Anti-Microbial Resistance, Novel Drug Discovery And Vaccine Development Organized By SRM University Haryana
Haryana (India), March 21: SRM University, Delhi-NCR, Sonepat, known for its contribution to science and technology, organized the Third International Conference on ‘Antimicrobial Resistance, Novel Drug Discovery, and Vaccine Development: Challenges and Opportunities,’ at the Habitat Centre, Delhi, from 18 to 20 March 2024. Participating in the conference were approximately four hundred delegates from India [...]
Haryana (India), March 21: SRM University, Delhi-NCR, Sonepat, known for its contribution to science and technology, organized the Third International Conference on ‘Antimicrobial Resistance, Novel Drug Discovery, and Vaccine Development: Challenges and Opportunities,’ at the Habitat Centre, Delhi, from 18 to 20 March 2024. Participating in the conference were approximately four hundred delegates from India and abroad. Distinguished international scientists in the field were plenary speakers across the three-day event.
The Conference was inaugurated by His Excellency, the Governor of Haryana, Shri Bandaru Dattatreya who expressed his appreciation for the organizers and complimented them on taking up an issue of global importance. In particular, he lauded the fact that eight countries were represented at the conference (UK, USA, Israel, S. Africa, Canada, Singapore, France, etc) and that the Guest of honour was the 2009 Nobel Laureate, Ada Yonath from Israel.
Antimicrobial resistance (AMR) occurs when microorganisms evolve to become resistant to the medications used to treat infections they cause, rendering these drugs less effective or ineffective. AMR arises from genetic mutations and misuse of antimicrobial medications. It poses a significant global health threat, leading to diseases that are difficult to treat, to increased mortality rates, and higher healthcare costs. Addressing AMR requires a comprehensive approach, including prudent antimicrobial use, surveillance, research into new treatments, and collaboration across healthcare sectors and stakeholders. In the face of mounting challenges posed by antimicrobial resistance, the urgency to discover novel drugs and develop effective vaccines has never been greater.
